Malaria chemoprophylaxis: Difference between revisions
From IDWiki
No edit summary |
(→) |
||
Line 35: | Line 35: | ||
* Note that the medications that require 4 weeks after end of exposure are extended in this way because they do not treat the liver stage |
* Note that the medications that require 4 weeks after end of exposure are extended in this way because they do not treat the liver stage |
||
{| class="wikitable" |
{| class="wikitable sortable" |
||
! Medication !! Dose !! |
! Medication !! Dose !! Start !! Stop |
||
|- |
|- |
||
| [[Atovaquone-proguanil]] || 250 mg-100 mg po daily || 1 day before |
| [[Atovaquone-proguanil]] || 250 mg-100 mg po daily || 1 day before || 1 week after |
||
|- |
|- |
||
| [[Doxycycline]] || 100 mg po daily || 1 day before |
| [[Doxycycline]] || 100 mg po daily || 1 day before || 4 weeks after |
||
|- |
|- |
||
| [[Mefloquine]] || 250 mg po weekly || 1-3 weeks before |
| [[Mefloquine]] || 250 mg po weekly || 1-3 weeks before || 4 weeks after |
||
|- |
|- |
||
| [[Primaquine]] || 30 mg base po daily || 1 day before |
| [[Primaquine]] || 30 mg base po daily || 1 day before || 7 days after |
||
|- |
|- |
||
| [[Chloroquine]] || 300 mg po weekly || 1 week before |
| [[Chloroquine]] || 300 mg po weekly || 1 week before || 4 weeks after |
||
|- |
|- |
||
| [[Hydroxychloroquine]] || 310 mg base po weekly || 1 week before |
| [[Hydroxychloroquine]] || 310 mg base po weekly || 1 week before || 4 weeks after |
||
|} |
|} |
||
Revision as of 01:15, 30 April 2020
- Chemoprophylaxis is recommended for travelers to endemic areas
- Agent chosen based on the local drug-resistance, patient age, and pregnancy status
Chemoprophylaxis Selection
Chloroquine-sensitive regions
- Regions include Haiti, the Dominican Republic, Central America north of the Panama Canal, parts of Mexico, parts of South America, north Africa, parts of the Middle East, and west/central China
- See the CATMAT list for specific countries
- Drugs of choice
- Chloroquine (Aralen) preferred, though hydroxychloroquine (Plaquenil) is also acceptable
- Alternatives: atovaquone-proguanil, doxycycline, or mefloquine
Chloroquine-resistant regions
- Regions include most of sub-Saharan Africa, South America, Oceania and Asia
- See the CATMAT list for specific countries
- Some areas of Thailand, Myanmar (Burma), Laos and Cambodia, and southern Vietnam are both chloroquine-resistant and mefloquine-resistant
- Drugs of choice
- Atovaquone-proguanil
- Doxycycline
- Mefloquine
- Alternatives: Primaquine (contraindicated in G6PD deficiency and pregnancy)
Chloroquine-and mefloquine-resistant regions
- Regions include Asia, Africa and the Amazon basin, specifically in rural, wooded regions on the Thai borders with Myanmar, Cambodia, and Laos, as well as in southern Vietnam
- Drugs of choice
- Atovaquone-proguanil
- Doxycycline
- No approved drugs for pregnancy or children less than 5 kg, though atovaquone-proguanil may be considered after the first trimester
Pregnancy
- Mefloquine can be used, if they cannot avoid travelling to malaria-endemic areas
- Can cause neuropsychiatric symptoms
- Atovaquone-proguanil may be considered after the first trimester
Chemoprophylaxis Doses
- Note that the medications that require 4 weeks after end of exposure are extended in this way because they do not treat the liver stage
Medication | Dose | Start | Stop |
---|---|---|---|
Atovaquone-proguanil | 250 mg-100 mg po daily | 1 day before | 1 week after |
Doxycycline | 100 mg po daily | 1 day before | 4 weeks after |
Mefloquine | 250 mg po weekly | 1-3 weeks before | 4 weeks after |
Primaquine | 30 mg base po daily | 1 day before | 7 days after |
Chloroquine | 300 mg po weekly | 1 week before | 4 weeks after |
Hydroxychloroquine | 310 mg base po weekly | 1 week before | 4 weeks after |